aidx;assay_category;assay_cell_type;assay_chembl_id;assay_classifications;assay_organism;assay_parameters;assay_strain;assay_subcellular_fraction;assay_tax_id;assay_test_type;assay_tissue;assay_type;assay_type_description;bao_format;bao_label;cell_chembl_id;confidence_description;confidence_score;description;document_chembl_id;relationship_description;relationship_type;src_assay_id;src_id;target_chembl_id;tissue_chembl_id;variant_sequence
CLD0;;EMT6;CHEMBL675329;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of aerobic EMT6 tumor cells when exposed to concentration at 10E-4 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675330;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of aerobic EMT6 tumor cells when exposed to concentration at 10E-5 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675332;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of aerobic EMT6 tumor cells when exposed to concentration at 10e-6 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675333;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of aerobic EMT6 tumor cells when exposed to concentration at 10e-7 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675335;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of hypoxic EMT6 tumor cells when exposed to concentration at 10E-4 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675683;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of hypoxic EMT6 tumor cells when exposed to concentration at 10e-5 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675684;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of hypoxic EMT6 tumor cells when exposed to concentration at 10E-6 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;EMT6;CHEMBL675685;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307584;Target assigned is non-molecular;1;Compound was evaluated for its effect on survival of hypoxic EMT6 tumor cells when exposed to concentration at 10e-7 M;CHEMBL1123249;Non-molecular target assigned;N;;1;CHEMBL614294;;
CLD0;;L1210;CHEMBL700819;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Cytotoxicity was determined in vitro in murine leukemia L1210 Cells;CHEMBL1123327;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL878607;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;"In vitro inhibitory concentration required for 50% inhibition of L1210 cell growth;(ID 50*1E-12)";CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL706192;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Effect dose of 50 mg/kg on day 3, before L1210 cell transplantation in mice;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL704087;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Median survival time at a compound dose of 100 mg/kg, in mice bearing L1210 cells on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703630;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '200.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '200.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;"Median survival time at a compound dose of 200 mg/kg, in mice bearing L1210 cells on days 1 and 5; Toxic";CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703632;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Median survival time at a compound dose of 25 mg/Kg, in mice bearing L1210 cells on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703636;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;CHEMBL3308391;Target assigned is non-molecular;1;Median survival time at a compound dose of 50 mg/kg, in mice bearing L1210 cells on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;L1210;CHEMBL703642;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308391;Target assigned is non-molecular;1;Median survival time when no dose was administered in mice bearing L1210 cells on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL386;;
CLD0;;;CHEMBL746039;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of the median survival time (treated(T) versus control(C)) at a dose of 100 mg/kg, on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746040;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of the median survival time (treated(T) versus control(C)) at a dose of 25 mg/Kg on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL746041;[];Mus musculus;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}];;;10090.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Ratio of the median survival time (treated(T) versus control(C)) at a dose of 50 mg/kg, on days 1 and 5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL375;;
CLD0;;;CHEMBL784692;[{'assay_class_id': 96, 'bao_id': None, 'class_type': 'In vivo efficacy', 'l1': 'ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS', 'l2': 'Methods for Testing Immunological Factors', 'l3': 'Adjuvant Arthritis in Rats', 'source': 'Hock_2016'}];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiarthritic activity in rat determined by adjuvant arthritis assay in rat;CHEMBL1124517;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL784216;[];Rattus norvegicus;[];;;10116.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for dose at which there was no significant weight loss in rat at day 16;CHEMBL1124517;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL787479;[];Rattus norvegicus;[];;;10116.0;;;A;ADME;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Compound was tested for lethal dose at day 16 against rat;CHEMBL1124517;Non-molecular target assigned;N;;1;CHEMBL376;;
CLD0;;;CHEMBL847442;[];;[{'active': 1, 'comments': None, 'relation': '=', 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_type_fixed': 0, 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}];;;;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;The number of mice survived to that of total at a dose of 100 mg/kg on 30th day;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL848990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;The number of mice survived to that of total at a dose of 25 mg/Kg on 30th day: 4/5;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL848994;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;The number of mice survived to that of total at a dose of 50 mg/Kg on 30th day;CHEMBL1121878;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL852918;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;The number of mice survived to that of total when no compound dose was given on 30th day;CHEMBL1121878;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL911615;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of [3H]hypoxanthine uptake in Plasmodium falciparum 3D7;CHEMBL1138206;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL910502;[];Plasmodium falciparum;[];3D7;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiplasmodial activity against Plasmodium falciparum 3D7;CHEMBL1138206;Non-molecular target assigned;N;;1;CHEMBL364;;
CLD0;;;CHEMBL909307;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human HGPRT at pH 7.4;CHEMBL1138206;Direct protein target assigned;D;;1;CHEMBL2360;;
CLD0;;;CHEMBL910504;[];Plasmodium falciparum;[];;;5833.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Plasmodium falciparum HGXPRT at pH 7.4;CHEMBL1138206;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL911624;[];Plasmodium chabaudi;[];;;5825.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Plasmodium chabaudi 6 oxopurine phosphoribosyl transferase;CHEMBL1138206;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL911625;[];Plasmodium lophurae;[];;;5853.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Plasmodium lophurae 6 oxopurine phosphoribosyl transferase;CHEMBL1138206;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL853907;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human HGPRT at pH 8.5;CHEMBL1138206;Direct protein target assigned;D;;1;CHEMBL2360;;
CLD0;;;CHEMBL853908;[];Plasmodium falciparum;[];;;5833.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Plasmodium falciparum HGXPRT at pH 8.5;CHEMBL1138206;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Sphi609;CHEMBL853909;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Escherichia coli Sphi609 cells expressing Plasmodium falciparum HGXPRT;CHEMBL1138206;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Sphi609;CHEMBL853910;[];Escherichia coli;[];;;562.0;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of Escherichia coli Sphi609 cells expressing human HGPRT;CHEMBL1138206;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;Jurkat;CHEMBL854831;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Target assigned is non-molecular;1;Growth inhibition of Jurkat cell;CHEMBL1138218;Non-molecular target assigned;N;;1;CHEMBL397;;
CLD0;;Jurkat;CHEMBL854832;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Direct single protein target assigned;9;Growth inhibition of Jurkat cell overexpressing Bcl2;CHEMBL1138218;Direct protein target assigned;D;;1;CHEMBL4860;;
CLD0;;Jurkat;CHEMBL854833;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Direct single protein target assigned;9;Growth inhibition of Jurkat cell overexpressing BclXL;CHEMBL1138218;Direct protein target assigned;D;;1;CHEMBL4625;;
CLD0;;Jurkat;CHEMBL854834;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Default value - Target unknown or has yet to be assigned;0;Ratio of GI50 for Jurkat cells overexpressing Bcl2 or BclXL to normal Jurkat cells;CHEMBL1138218;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL905368;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of human xanthine oxidase;CHEMBL1143034;Direct protein target assigned;D;;1;CHEMBL1929;;
CLD0;;CCRF-CEM;CHEMBL905773;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Growth inhibition of human CCRF-CEM cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;K562;CHEMBL905774;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Growth inhibition of human K562 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;MOLT-4;CHEMBL905775;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;Growth inhibition of human MOLT4 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614177;;
CLD0;;RPMI-8226;CHEMBL905776;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;Growth inhibition of human RPMI8226 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614882;;
CLD0;;A549;CHEMBL905777;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Growth inhibition of human A549 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;EKVX ;CHEMBL905778;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;Growth inhibition of human EKVX cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614487;;
CLD0;;HOP-62;CHEMBL905779;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;Growth inhibition of human HOP62 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614643;;
CLD0;;HOP-92;CHEMBL905780;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;Growth inhibition of human HOP92 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL613889;;
CLD0;;NCI-H226;CHEMBL905781;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;Growth inhibition of human NCI-H226 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614740;;
CLD0;;NCI-H23;CHEMBL905782;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;Growth inhibition of human NCI-H23 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614997;;
CLD0;;NCI-H322M;CHEMBL905783;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307710;Target assigned is non-molecular;1;Growth inhibition of human NCI-H322M cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614803;;
CLD0;;NCI-H460;CHEMBL905784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Growth inhibition of human NCI-H460 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL396;;
CLD0;;NCI-H522;CHEMBL905785;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;Growth inhibition of human NCI-H522 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614387;;
CLD0;;COLO 205;CHEMBL905786;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;Growth inhibition of human COLO205 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614561;;
CLD0;;HCC 2998;CHEMBL905787;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308074;Target assigned is non-molecular;1;Growth inhibition of human HCC2998 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL613855;;
CLD0;;HCT-116;CHEMBL905788;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Growth inhibition of human HCT116 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL394;;
CLD0;;HCT-15;CHEMBL905789;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;Growth inhibition of human HCT15 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL612263;;
CLD0;;HT-29;CHEMBL905790;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Growth inhibition of human HT29 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;KM12;CHEMBL905791;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;Growth inhibition of human KM12 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614709;;
CLD0;;SW-620;CHEMBL905792;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;Growth inhibition of human SW620 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL612262;;
CLD0;;SF-268;CHEMBL905793;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Growth inhibition of human SF268 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL613977;;
CLD0;;SF-295;CHEMBL905794;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;Growth inhibition of human SF295 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614908;;
CLD0;;SF-539;CHEMBL905795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;Growth inhibition of human SF539 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614860;;
CLD0;;SNB-19;CHEMBL905796;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;Growth inhibition of human SNB19 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614164;;
CLD0;;SNB-75;CHEMBL905797;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;Growth inhibition of human SNB75 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614451;;
CLD0;;U-251;CHEMBL905798;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;Growth inhibition human U251 of cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL615022;;
CLD0;;LOX IMVI ;CHEMBL905799;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;Growth inhibition of human LOX IMVI cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614096;;
CLD0;;M14;CHEMBL905800;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;Growth inhibition of human M14 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614317;;
CLD0;;SK-MEL-2;CHEMBL905801;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;Growth inhibition of human SK-MEL-2 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614917;;
CLD0;;SK-MEL-28;CHEMBL905802;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;Growth inhibition of human SK-MEL-28 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614919;;
CLD0;;SK-MEL-5;CHEMBL906887;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;Growth inhibition of human SK-MEL-5 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614922;;
CLD0;;UACC-257;CHEMBL906865;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;Growth inhibition of human UACC257 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL612796;;
CLD0;;UACC-62;CHEMBL906866;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;Growth inhibition of human UACC62 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614610;;
CLD0;;IGROV-1;CHEMBL906867;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;Growth inhibition of human IGROV1 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL613984;;
CLD0;;OVCAR-3;CHEMBL906868;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Growth inhibition of human OVCAR-3 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614213;;
CLD0;;OVCAR-4;CHEMBL906869;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;Growth inhibition of human OVCAR4 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614051;;
CLD0;;OVCAR-8;CHEMBL906870;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;Growth inhibition of human OVCAR8 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL612555;;
CLD0;;SK-OV-3;CHEMBL906871;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Growth inhibition of human SK-OV-3 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614925;;
CLD0;;786-0;CHEMBL906872;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;CHEMBL3308018;Target assigned is non-molecular;1;Growth inhibition of human 786O cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;A498;CHEMBL906873;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;Growth inhibition of human A498 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614516;;
CLD0;;ACHN;CHEMBL906874;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;Growth inhibition of human ACHN cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614519;;
CLD0;;CAKI-1;CHEMBL906875;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;Growth inhibition of human CAKI1 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614067;;
CLD0;;RXF 393;CHEMBL906876;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;Growth inhibition of human RXF393 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614886;;
CLD0;;SN12C;CHEMBL906877;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;Growth inhibition of human SN12C cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614054;;
CLD0;;TK-10;CHEMBL906878;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;Growth inhibition of human TK10 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614056;;
CLD0;;UO-31;CHEMBL906879;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;Growth inhibition of human UO31 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614388;;
CLD0;;PC-3;CHEMBL906880;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Growth inhibition of human PC3 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL390;;
CLD0;;DU-145;CHEMBL906881;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Growth inhibition of human DU145 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL613508;;
CLD0;;MCF7;CHEMBL906882;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Growth inhibition of human MCF7 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL387;;
CLD0;;MDA-MB-231;CHEMBL906884;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;Growth inhibition of MDA-MB-231 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL400;;
CLD0;;Hs-578T;CHEMBL906885;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307672;Target assigned is non-molecular;1;Growth inhibition of human HS578T cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614645;;
CLD0;;MDA-MB-435;CHEMBL906886;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Growth inhibition of human MDA-MB-435 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614697;;
CLD0;;BT-549;CHEMBL906888;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;Growth inhibition of human BT549 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614072;;
CLD0;;T47D;CHEMBL906889;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;Growth inhibition of human T47D cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614361;;
CLD0;;OVCAR-5;CHEMBL906890;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;Growth inhibition of human OVCAR5 cells after 48 hrs by SRB protein assay;CHEMBL1143799;Non-molecular target assigned;N;;1;CHEMBL614214;;
CLD0;;;CHEMBL934454;[];;[];;;;;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;Inhibition of PAK1 at 31 uM;CHEMBL1141629;Homologous protein target assigned;H;;1;CHEMBL4600;;
CLD0;;HT-29;CHEMBL981345;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981346;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 10 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981347;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981348;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;HT-29;CHEMBL981349;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Antiproliferative activity against human HT-29 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL384;;
CLD0;;P388;CHEMBL981350;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981351;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981352;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.1 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;P388;CHEMBL981353;[];Mus musculus;[];;;10090.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;Antiproliferative activity against mouse P388 cells at 0.01 ug after 48 hrs by two-layer agar-diffusion method;CHEMBL1147285;Non-molecular target assigned;N;;1;CHEMBL389;;
CLD0;;;CHEMBL997825;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of beta-hexosaminidase A at pH 4.3 assessed as residual enzyme activity;CHEMBL1156436;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
CLD0;;;CHEMBL965577;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse liver MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965578;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOA;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3681;;
CLD0;;;CHEMBL965580;[];Mus musculus;[];;;10090.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Inhibition of mouse brain MAOB;CHEMBL1152129;Direct protein target assigned;D;;1;CHEMBL3050;;
CLD0;;CCRF-CEM;CHEMBL1055751;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1055752;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;HL-60;CHEMBL1055754;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL383;;
CLD0;;HL60/MX2;CHEMBL1055755;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295458;Target assigned is non-molecular;1;Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay;CHEMBL1153537;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;;CHEMBL1108963;[];;[];;;;;;P;Physicochemical;BAO_0000100;small-molecule physicochemical format;;Default value - Target unknown or has yet to be assigned;0;Octanol-water partition coefficient, log P of the compound;CHEMBL1157036;Default value - Target has yet to be curated;U;;1;CHEMBL2362975;;
CLD0;;A549;CHEMBL1247283;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Cytotoxicity against human A549 cells after 72 hrs by MTT assay;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL392;;
CLD0;;CCRF-CEM;CHEMBL1247284;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cytotoxicity against human CEM cells after 72 hrs by MTT assay;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;;CHEMBL1247285;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human CEM-DNR-B cells after 72 hrs by MTT assay;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL3879801;;
CLD0;;K562;CHEMBL1247286;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human K562 cells after 72 hrs by MTT assay;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;K562;CHEMBL1247287;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Cytotoxicity against human paclitaxel-resistant K562 cells after 72 hrs by MTT assay;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL1247288;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Induction of apoptosis in human CEM cells using propidium iodide staining at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247289;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Induction of apoptosis in human CEM cells using propidium iodide staining at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247290;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at G0/G1 phase using propidium iodide staining at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247291;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at G0/G1 phase using propidium iodide staining at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247455;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at S phase using propidium iodide staining at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247456;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at S phase using propidium iodide staining at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247457;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at G2/M phase using propidium iodide staining at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Cell cycle arrest in human CEM cells assessed as accumulation at G2/M phase using propidium iodide staining at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247459;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibition of RNA synthesis in human CEM cells assessed as BrU incorporation using propidium iodide staining at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247460;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibition of RNA synthesis in human CEM cells assessed as BrU incorporation using propidium iodide staining at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247461;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibition of DNA synthesis in human CEM cells assessed as BrDU incorporation using propidium iodide staining at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247462;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Inhibition of DNA synthesis in human CEM cells assessed as BrDU incorporation using propidium iodide staining at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247463;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Induction of mitotic arrest in human CEM cells assessed as pH3Ser10 positive cells at IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;;CCRF-CEM;CHEMBL1247464;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Induction of mitotic arrest in human CEM cells assessed as pH3Ser10 positive cells at 5 times IC50 concentration after 24 hrs by flow cytometry;CHEMBL1240455;Non-molecular target assigned;N;;1;CHEMBL382;;
CLD0;confirmatory;;CHEMBL1614445;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation and Secondary Assays for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 and 705 loci. (Class of assay: confirmatory) [Related pubchem assays: 910, 931, 925, 930 ];CHEMBL1201862;Direct protein target assigned;D;1405;7;CHEMBL4331;;
CLD0;confirmatory;;CHEMBL1614458;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))];CHEMBL1201862;Direct protein target assigned;D;1030;7;CHEMBL3577;;
CLD0;confirmatory;;CHEMBL1614204;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;910;7;CHEMBL4331;;
CLD0;confirmatory;;CHEMBL1614275;[];Giardia intestinalis;[];;;5741.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ];CHEMBL1201862;Direct protein target assigned;D;2451;7;CHEMBL1293234;;
CLD0;confirmatory;CHO;CHEMBL1614463;[];Cricetulus griseus;[];;;10029.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308072;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Mammalian cellular toxicity. (Class of assay: confirmatory) [Related pubchem assays: 2451, 2472, 2464 ];CHEMBL1201862;Non-molecular target assigned;N;2786;7;CHEMBL613853;;
CLD0;confirmatory;;CHEMBL1613970;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1948;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613976;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;930;7;CHEMBL4331;;
CLD0;confirmatory;;CHEMBL1613992;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;902;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL1613995;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ];CHEMBL1201862;Direct protein target assigned;D;924;7;CHEMBL4096;;
CLD0;confirmatory;;CHEMBL1614038;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))];CHEMBL1201862;Direct protein target assigned;D;894;7;CHEMBL1293255;;
CLD0;confirmatory;;CHEMBL1614211;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;2517;7;CHEMBL5619;;
CLD0;confirmatory;;CHEMBL1613842;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;1458;7;CHEMBL1293232;;
CLD0;confirmatory;;CHEMBL1613892;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi using a modified counterscreen. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1985;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1613923;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella typhi identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 1985 ];CHEMBL1201862;Default value - Target has yet to be curated;U;2252;7;CHEMBL612545;;
CLD0;;;CHEMBL1690567;[];Bacillus anthracis str. Sterne;[];34F2;;260799.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Inhibition of inosine/L-alanine-induced Bacillus anthracis Sterne 34F2 spore germination pretreated for 15 mins before inosine/L-alanine challenge;CHEMBL1687814;Non-molecular target assigned;N;;1;CHEMBL613904;;
CLD0;;;CHEMBL1690568;[];Bacillus anthracis str. Sterne;[];34F2;;260799.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antibacterial activity against Bacillus anthracis Sterne 34F2 infected in mouse J774A.1 cells assessed as protection against bacteria-induced cytotoxicity using propidium iodide staining after 3 hrs measured every hours for up to 7 hrs;CHEMBL1687814;Non-molecular target assigned;N;;1;CHEMBL613904;;
CLD0;;J774.A1;CHEMBL1690571;[];Mus musculus;[];;;10090.0;;;A;ADME;BAO_0000219;cell-based format;CHEMBL3307516;Target assigned is non-molecular;1;Cytotoxicity against mouse J774A1 cells;CHEMBL1687814;Non-molecular target assigned;N;;1;CHEMBL614040;;
CLD0;;;CHEMBL1690572;[];Bacillus anthracis str. Sterne;[];34F2;;260799.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antibacterial activity against Bacillus anthracis Sterne 34F2 infected in mouse J774A.1 cells assessed as protection against bacteria-induced cytotoxicity using propidium iodide staining measured after 6 hrs infection;CHEMBL1687814;Non-molecular target assigned;N;;1;CHEMBL613904;;
CLD0;;;CHEMBL1697722;[];;[];;;;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset;CHEMBL1697692;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697730;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Human drug-induced liver injury (DILI) modelling dataset from Ekins et al;CHEMBL1697723;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697778;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697779;[];Rodentia;[];;;9989.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697780;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents;CHEMBL1697731;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697797;[];Homo sapiens;[];;;9606.0;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA HLAED, liver enzyme composite activity;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1697798;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, alkaline phosphatase increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697799;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697800;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697801;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, lactate dehydrogenase (LDH) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;;;CHEMBL1697802;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000019;assay format;;Target assigned is non-molecular;1;FDA HLAED, gamma-glutamyl transferase (GGT) increase;CHEMBL1697781;Non-molecular target assigned;N;;1;CHEMBL1697861;;
CLD0;confirmatory;Jurkat;CHEMBL1738369;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307526;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465];CHEMBL1201862;Default value - Target has yet to be curated;U;489035;7;CHEMBL612545;;
CLD0;confirmatory;HEK-293T;CHEMBL1738494;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489041];CHEMBL1201862;Default value - Target has yet to be curated;U;489026;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738552;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465];CHEMBL1201862;Default value - Target has yet to be curated;U;489033;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1738593;[];Trypanosoma brucei TREU927;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768];CHEMBL1201862;Homologous protein target assigned;H;504636;7;CHEMBL5686;;
CLD0;confirmatory;HEK-293T;CHEMBL1737912;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026];CHEMBL1201862;Default value - Target has yet to be curated;U;489041;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL1737991;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402];CHEMBL1201862;Direct protein target assigned;D;504339;7;CHEMBL5896;;
CLD0;confirmatory;;CHEMBL1738173;[];Trypanosoma brucei TREU927;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of T. brucei phosphofructokinase: Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768];CHEMBL1201862;Homologous protein target assigned;H;504637;7;CHEMBL5686;;
CLD0;confirmatory;;CHEMBL1738184;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648];CHEMBL1201862;Direct protein target assigned;D;504444;7;CHEMBL1075094;;
CLD0;confirmatory;;CHEMBL1738442;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404];CHEMBL1201862;Direct protein target assigned;D;504332;7;CHEMBL6032;;
CLD0;confirmatory;;CHEMBL1614292;[];Trypanosoma brucei TREU927;[];;;185431.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961];CHEMBL1201862;Homologous protein target assigned;H;485367;7;CHEMBL5686;;
CLD0;confirmatory;;CHEMBL1794345;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504834;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794499;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856];CHEMBL1201862;Homologous protein target assigned;H;504845;7;CHEMBL1795091;;
CLD0;confirmatory;;CHEMBL1794512;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178];CHEMBL1201862;Default value - Target has yet to be curated;U;540303;7;CHEMBL612545;;
CLD0;confirmatory;HepG2;CHEMBL1794553;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860];CHEMBL1201862;Non-molecular target assigned;N;588856;7;CHEMBL395;;
CLD0;confirmatory;;CHEMBL1794580;[];Plasmodium falciparum;[];;;5833.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850];CHEMBL1201862;Non-molecular target assigned;N;504832;7;CHEMBL364;;
CLD0;confirmatory;;CHEMBL1794584;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860];CHEMBL1201862;Homologous protein target assigned;H;588855;7;CHEMBL1293258;;
CLD0;;;CHEMBL1909163;[];Cavia porcellus;[];;;10141.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4);CHEMBL1909046;Direct protein target assigned;D;67;15;CHEMBL1909043;CHEMBL3638235;
CLD0;;CHO-K1;CHEMBL1909164;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4);CHEMBL1909046;Homologous protein target assigned;H;68;15;CHEMBL1798;;
CLD0;;Reticulocytes;CHEMBL1909165;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid);CHEMBL1909046;Direct protein target assigned;D;69;15;CHEMBL4358;;
CLD0;;HEK293;CHEMBL1909166;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;70;15;CHEMBL4644;;
CLD0;;HEK293;CHEMBL1909167;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;71;15;CHEMBL259;;
CLD0;;HEK293;CHEMBL1909168;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH);CHEMBL1909046;Homologous protein target assigned;H;72;15;CHEMBL4608;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909169;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine);CHEMBL1909046;Homologous protein target assigned;H;73;15;CHEMBL1951;;
CLD0;;CHO-K1;CHEMBL1909170;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;74;15;CHEMBL216;;
CLD0;;CHO-K1;CHEMBL1909171;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;75;15;CHEMBL211;;
CLD0;;CHO-K1;CHEMBL1909172;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;76;15;CHEMBL245;;
CLD0;;CHO-K1;CHEMBL1909173;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;77;15;CHEMBL1821;;
CLD0;;CHO-K1;CHEMBL1909174;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine);CHEMBL1909046;Homologous protein target assigned;H;78;15;CHEMBL2035;;
CLD0;;SK-N-MC;CHEMBL1909175;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307551;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;79;15;CHEMBL4777;;
CLD0;;KAN-TS;CHEMBL1909176;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY);CHEMBL1909046;Homologous protein target assigned;H;80;15;CHEMBL4018;;
CLD0;;IMR-32;CHEMBL1909177;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307656;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine);CHEMBL1909046;Default value - Target has yet to be curated;U;81;15;CHEMBL612545;;
CLD0;;;CHEMBL1909178;[];Rattus norvegicus;[];;;10116.0;In vitro;Cerebellum;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine);CHEMBL1909046;Direct protein target assigned;D;82;15;CHEMBL3048;CHEMBL3638233;
CLD0;;;CHEMBL1909179;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine);CHEMBL1909046;Homologous protein target assigned;H;83;15;CHEMBL3464;;
CLD0;;HEK293;CHEMBL1909180;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole);CHEMBL1909046;Homologous protein target assigned;H;84;15;CHEMBL236;;
CLD0;;HEK293;CHEMBL1909181;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;85;15;CHEMBL237;;
CLD0;;CHO-K1;CHEMBL1909182;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine);CHEMBL1909046;Homologous protein target assigned;H;86;15;CHEMBL233;;
CLD0;;;CHEMBL1909183;[];Mus musculus;[];ICR;Membrane;10090.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu);CHEMBL1909046;Default value - Target has yet to be curated;U;87;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Platelet;CHEMBL1909184;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;88;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909185;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP);CHEMBL1909046;Default value - Target has yet to be curated;U;89;15;CHEMBL612545;;
CLD0;;Platelet;CHEMBL1909186;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP);CHEMBL1909046;Direct protein target assigned;D;90;15;CHEMBL1827;;
CLD0;;Platelet;CHEMBL1909187;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF);CHEMBL1909046;Direct protein target assigned;D;91;15;CHEMBL250;;
CLD0;;NIH3T3;CHEMBL1909188;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF);CHEMBL1909046;Default value - Target has yet to be curated;U;92;15;CHEMBL612545;;
CLD0;;HIT-T15;CHEMBL1909189;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide);CHEMBL1909046;Default value - Target has yet to be curated;U;93;15;CHEMBL612545;;
CLD0;;HEK293;CHEMBL1909190;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);CHEMBL1909046;Homologous protein target assigned;H;94;15;CHEMBL240;;
CLD0;;;CHEMBL1909191;[];Bos taurus;[];;;9913.0;In vitro;Uterus;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020);CHEMBL1909046;Direct protein target assigned;D;95;15;CHEMBL1909044;CHEMBL3638197;
CLD0;;;CHEMBL1909192;[];Oryctolagus cuniculus;[];;;9986.0;In vitro;Lung;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG);CHEMBL1909046;Direct protein target assigned;D;96;15;CHEMBL4074;CHEMBL3638235;
CLD0;;;CHEMBL1909193;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC);CHEMBL1909046;Homologous protein target assigned;H;97;15;CHEMBL4801;;
CLD0;;Neutrophil;CHEMBL1909194;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC);CHEMBL1909046;Direct protein target assigned;D;98;15;CHEMBL4071;;
CLD0;;Neutrophil;CHEMBL1909195;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3308052;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA);CHEMBL1909046;Direct protein target assigned;D;99;15;CHEMBL248;;
CLD0;;;CHEMBL1909196;[];Homo sapiens;[];;;9606.0;In vitro;Rheumatoid synovial fibroblasts;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Direct protein target assigned;D;100;15;CHEMBL332;;
CLD0;;;CHEMBL1909197;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2);CHEMBL1909046;Homologous protein target assigned;H;101;15;CHEMBL321;;
CLD0;;Sf9;CHEMBL1909198;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone);CHEMBL1909046;Homologous protein target assigned;H;102;15;CHEMBL299;;
CLD0;;;CHEMBL1909199;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;103;15;CHEMBL3385;;
CLD0;;;CHEMBL1909200;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;104;15;CHEMBL4040;;
CLD0;;;CHEMBL1909201;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein);CHEMBL1909046;Homologous protein target assigned;H;105;15;CHEMBL260;;
CLD0;;;CHEMBL1909202;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;106;15;CHEMBL4445;;
CLD0;;Insect cells;CHEMBL1909203;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;107;15;CHEMBL203;;
CLD0;;Insect cells;CHEMBL1909204;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;108;15;CHEMBL1841;;
CLD0;;Insect cells;CHEMBL1909205;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;109;15;CHEMBL1824;;
CLD0;;Insect cells;CHEMBL1909206;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr));CHEMBL1909046;Homologous protein target assigned;H;110;15;CHEMBL258;;
CLD0;;;CHEMBL1909207;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP);CHEMBL1909046;Homologous protein target assigned;H;111;15;CHEMBL3243;;
CLD0;;;CHEMBL1909208;[];Oryctolagus cuniculus;[];New Zealand albino;Membrane;9986.0;In vitro;Urinary bladder;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;112;15;CHEMBL612545;CHEMBL3638205;
CLD0;;CHO-K1;CHEMBL1909209;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT);CHEMBL1909046;Homologous protein target assigned;H;113;15;CHEMBL273;;
CLD0;;;CHEMBL1909210;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Direct protein target assigned;D;114;15;CHEMBL3459;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909211;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin);CHEMBL1909046;Homologous protein target assigned;H;115;15;CHEMBL224;;
CLD0;;HEK293;CHEMBL1909212;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine);CHEMBL1909046;Homologous protein target assigned;H;1;15;CHEMBL220;;
CLD0;;CHO;CHEMBL1909213;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX);CHEMBL1909046;Homologous protein target assigned;H;2;15;CHEMBL226;;
CLD0;;HEK293;CHEMBL1909214;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;3;15;CHEMBL251;;
CLD0;;CHO-K1;CHEMBL1909215;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA);CHEMBL1909046;Homologous protein target assigned;H;4;15;CHEMBL256;;
CLD0;;;CHEMBL1909084;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine);CHEMBL1909046;Default value - Target has yet to be curated;U;5;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909085;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Submaxillary gland;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;6;15;CHEMBL319;CHEMBL3987361;
CLD0;;;CHEMBL1909086;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Direct protein target assigned;D;7;15;CHEMBL315;CHEMBL3559723;
CLD0;;HEK293;CHEMBL1909087;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin);CHEMBL1909046;Homologous protein target assigned;H;8;15;CHEMBL223;;
CLD0;;Sf9;CHEMBL1909088;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912);CHEMBL1909046;Homologous protein target assigned;H;9;15;CHEMBL1867;;
CLD0;;CHO-K1;CHEMBL1909089;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine);CHEMBL1909046;Homologous protein target assigned;H;10;15;CHEMBL1942;;
CLD0;;Sf9;CHEMBL1909090;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912);CHEMBL1909046;Homologous protein target assigned;H;11;15;CHEMBL1916;;
CLD0;;CHO-K1;CHEMBL1909091;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;12;15;CHEMBL213;;
CLD0;;CHO;CHEMBL1909092;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177);CHEMBL1909046;Homologous protein target assigned;H;13;15;CHEMBL210;;
CLD0;;HEK293;CHEMBL1909093;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol);CHEMBL1909046;Homologous protein target assigned;H;14;15;CHEMBL246;;
CLD0;;MDCK;CHEMBL1909094;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308370;Homologous single protein target assigned;8;DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;15;15;CHEMBL222;;
CLD0;;;CHEMBL1909095;[];Rattus norvegicus;[];;;10116.0;In vitro;Lens of camera-type eye;B;Binding;BAO_0000221;tissue-based format;;Direct single protein target assigned;9;DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde);CHEMBL1909046;Direct protein target assigned;D;16;15;CHEMBL2622;CHEMBL3638191;
CLD0;;CHO-K1;CHEMBL1909096;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A);CHEMBL1909046;Homologous protein target assigned;H;17;15;CHEMBL4607;;
CLD0;;;CHEMBL1909097;[];Sus scrofa;[];;;9823.0;In vitro;Heart;B;Binding;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP);CHEMBL1909046;Default value - Target has yet to be curated;U;18;15;CHEMBL612545;CHEMBL3638187;
CLD0;;;CHEMBL1909098;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Adrenal gland;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat));CHEMBL1909046;Default value - Target has yet to be curated;U;19;15;CHEMBL612545;CHEMBL3638251;
CLD0;;;CHEMBL1909099;[];Bacillus cereus;[];;;1396.0;In vitro;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin);CHEMBL1909046;Default value - Target has yet to be curated;U;20;15;CHEMBL612545;;
CLD0;;Chem-1;CHEMBL1909100;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin);CHEMBL1909046;Homologous protein target assigned;H;21;15;CHEMBL3157;;
CLD0;;T47D;CHEMBL1909101;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307606;Homologous single protein target assigned;8;DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon));CHEMBL1909046;Homologous protein target assigned;H;22;15;CHEMBL1832;;
CLD0;;;CHEMBL1909102;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem);CHEMBL1909046;Default value - Target has yet to be curated;U;23;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909103;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine);CHEMBL1909046;Default value - Target has yet to be curated;U;24;15;CHEMBL612545;CHEMBL3559724;
CLD0;;CHO-K1;CHEMBL1909104;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;116;15;CHEMBL1833;;
CLD0;;CHO-K1;CHEMBL1909105;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine);CHEMBL1909046;Homologous protein target assigned;H;117;15;CHEMBL225;;
CLD0;;HEK293;CHEMBL1909106;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630);CHEMBL1909046;Default value - Target has yet to be curated;U;118;15;CHEMBL612545;;
CLD0;;;CHEMBL1909107;[];Cavia porcellus;[];Dunkin-Hartley;Membrane;10141.0;In vitro;Striatum;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808);CHEMBL1909046;Direct protein target assigned;D;119;15;CHEMBL5017;CHEMBL3638255;
CLD0;;HeLa;CHEMBL1909108;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308376;Homologous single protein target assigned;8;DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide);CHEMBL1909046;Homologous protein target assigned;H;120;15;CHEMBL3371;;
CLD0;;HEK293;CHEMBL1909109;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine);CHEMBL1909046;Homologous protein target assigned;H;121;15;CHEMBL228;;
CLD0;;Jurkat;CHEMBL1909110;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307526;Homologous single protein target assigned;8;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CHEMBL1909046;Homologous protein target assigned;H;122;15;CHEMBL287;;
CLD0;;;CHEMBL1909111;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil);CHEMBL1909046;Default value - Target has yet to be curated;U;123;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909112;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin);CHEMBL1909046;Default value - Target has yet to be curated;U;124;15;CHEMBL612545;CHEMBL3638188;
CLD0;;CHO;CHEMBL1909113;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P);CHEMBL1909046;Homologous protein target assigned;H;125;15;CHEMBL249;;
CLD0;;CHO;CHEMBL1909114;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968);CHEMBL1909046;Homologous protein target assigned;H;126;15;CHEMBL2327;;
CLD0;;;CHEMBL1909115;[];Escherichia coli;[];;Membrane;562.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone);CHEMBL1909046;Homologous protein target assigned;H;127;15;CHEMBL3072;;
CLD0;;Platelet;CHEMBL1909116;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2);CHEMBL1909046;Direct protein target assigned;D;128;15;CHEMBL1835;;
CLD0;;U-937;CHEMBL1909117;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha);CHEMBL1909046;Default value - Target has yet to be curated;U;129;15;CHEMBL612545;;
CLD0;;HUVEC;CHEMBL1909118;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307501;Homologous single protein target assigned;8;DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF);CHEMBL1909046;Homologous protein target assigned;H;130;15;CHEMBL1868;;
CLD0;;HT-29;CHEMBL1909119;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307768;Homologous single protein target assigned;8;DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP);CHEMBL1909046;Homologous protein target assigned;H;131;15;CHEMBL5144;;
CLD0;;HEK293;CHEMBL1909120;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr);CHEMBL1909046;Homologous protein target assigned;H;132;15;CHEMBL1889;;
CLD0;;;CHEMBL1909121;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888));CHEMBL1909046;Default value - Target has yet to be curated;U;25;15;CHEMBL612545;CHEMBL3638188;
CLD0;;Chem-1;CHEMBL1909122;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A);CHEMBL1909046;Homologous protein target assigned;H;26;15;CHEMBL218;;
CLD0;;Erythrocyte;CHEMBL1909123;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833281;Direct single protein target assigned;9;DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA));CHEMBL1909046;Direct protein target assigned;D;27;15;CHEMBL205;;
CLD0;;CHO-K1;CHEMBL1909124;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1);CHEMBL1909046;Homologous protein target assigned;H;28;15;CHEMBL4015;;
CLD0;;Chem-1;CHEMBL1909125;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC);CHEMBL1909046;Homologous protein target assigned;H;29;15;CHEMBL2414;;
CLD0;;HEK293;CHEMBL1909126;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307715;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha);CHEMBL1909046;Homologous protein target assigned;H;30;15;CHEMBL274;;
CLD0;;;CHEMBL1909127;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR1 (IL-8A);CHEMBL1909046;Homologous protein target assigned;H;31;15;CHEMBL4029;;
CLD0;;CHO-K1;CHEMBL1909128;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8);CHEMBL1909046;Homologous protein target assigned;H;32;15;CHEMBL2434;;
CLD0;;1321-N1;CHEMBL1909129;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;;Homologous single protein target assigned;8;DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718);CHEMBL1909046;Homologous protein target assigned;H;33;15;CHEMBL1901;;
CLD0;;Platelet;CHEMBL1909130;[];Homo sapiens;[];;;9606.0;In vitro;;B;Binding;BAO_0000221;tissue-based format;CHEMBL3833781;Direct single protein target assigned;9;DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Direct protein target assigned;D;34;15;CHEMBL221;;
CLD0;;Sf21;CHEMBL1909131;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL4106362;Homologous single protein target assigned;8;DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid);CHEMBL1909046;Homologous protein target assigned;H;35;15;CHEMBL230;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909132;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;36;15;CHEMBL3356;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909133;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;37;15;CHEMBL5282;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909134;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;38;15;CHEMBL3622;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909135;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;39;15;CHEMBL3397;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909136;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;40;15;CHEMBL289;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909137;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin);CHEMBL1909046;Homologous protein target assigned;H;41;15;CHEMBL5281;;
CLD0;;BTI-TN-5B1-4;CHEMBL1909138;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3833782;Homologous single protein target assigned;8;DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin);CHEMBL1909046;Homologous protein target assigned;H;42;15;CHEMBL340;;
CLD0;;CHO;CHEMBL1909139;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390);CHEMBL1909046;Homologous protein target assigned;H;43;15;CHEMBL2056;;
CLD0;;CHO;CHEMBL1909140;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;44;15;CHEMBL217;;
CLD0;;CHO;CHEMBL1909141;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308072;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;45;15;CHEMBL234;;
CLD0;;CHO-K1;CHEMBL1909142;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone);CHEMBL1909046;Homologous protein target assigned;H;46;15;CHEMBL219;;
CLD0;;CHO-K1;CHEMBL1909143;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55);CHEMBL1909046;Homologous protein target assigned;H;47;15;CHEMBL238;;
CLD0;;CHO-K1;CHEMBL1909144;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1);CHEMBL1909046;Homologous protein target assigned;H;48;15;CHEMBL252;;
CLD0;;Sf9;CHEMBL1909145;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;49;15;CHEMBL206;;
CLD0;;Sf9;CHEMBL1909146;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3308860;Homologous single protein target assigned;8;DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol);CHEMBL1909046;Homologous protein target assigned;H;50;15;CHEMBL242;;
CLD0;;;CHEMBL1909147;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol);CHEMBL1909046;Default value - Target has yet to be curated;U;51;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909148;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam);CHEMBL1909046;Default value - Target has yet to be curated;U;52;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909149;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB);CHEMBL1909046;Default value - Target has yet to be curated;U;53;15;CHEMBL612545;CHEMBL3559724;
CLD0;;HeLa S3;CHEMBL1909150;[];;[];;;32644.0;In vitro;;B;Binding;BAO_0000219;cell-based format;CHEMBL3886002;Homologous single protein target assigned;8;DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone);CHEMBL1909046;Homologous protein target assigned;H;54;15;CHEMBL2034;;
CLD0;;;CHEMBL1909151;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA);CHEMBL1909046;Default value - Target has yet to be curated;U;55;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909152;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Brain;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid);CHEMBL1909046;Default value - Target has yet to be curated;U;56;15;CHEMBL612545;CHEMBL3638188;
CLD0;;;CHEMBL1909153;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653);CHEMBL1909046;Default value - Target has yet to be curated;U;57;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909154;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP);CHEMBL1909046;Default value - Target has yet to be curated;U;58;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909155;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Spinal cord;B;Binding;BAO_0000249;cell membrane format;;Multiple direct protein targets may be assigned;5;DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine);CHEMBL1909046;Direct protein target assigned;D;59;15;CHEMBL3392921;CHEMBL3638246;
CLD0;;CHO-K1;CHEMBL1909156;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine);CHEMBL1909046;Homologous protein target assigned;H;60;15;CHEMBL231;;
CLD0;;CHO-K1;CHEMBL1909157;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307512;Homologous single protein target assigned;8;DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine);CHEMBL1909046;Homologous protein target assigned;H;61;15;CHEMBL1941;;
CLD0;;;CHEMBL1909158;[];Escherichia coli;[];;;562.0;In vitro;;B;Binding;BAO_0000357;single protein format;;Homologous single protein target assigned;8;DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA);CHEMBL1909046;Homologous protein target assigned;H;62;15;CHEMBL402;;
CLD0;;;CHEMBL1909159;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Cerebral cortex;B;Binding;BAO_0000249;cell membrane format;;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan);CHEMBL1909046;Default value - Target has yet to be curated;U;63;15;CHEMBL612545;CHEMBL3559724;
CLD0;;;CHEMBL1909160;[];Rattus norvegicus;[];Wistar;Membrane;10116.0;In vitro;Liver;B;Binding;BAO_0000249;cell membrane format;;Direct single protein target assigned;9;DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin);CHEMBL1909046;Direct protein target assigned;D;64;15;CHEMBL5486;CHEMBL3559723;
CLD0;;NIH3T3;CHEMBL1909161;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3307716;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta);CHEMBL1909046;Default value - Target has yet to be curated;U;65;15;CHEMBL612545;;
CLD0;;U-937;CHEMBL1909162;[];;[];;Membrane;32644.0;In vitro;;B;Binding;BAO_0000249;cell membrane format;CHEMBL3308006;Default value - Target unknown or has yet to be assigned;0;DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4);CHEMBL1909046;Default value - Target has yet to be curated;U;66;15;CHEMBL612545;;
CLD0;;;CHEMBL1909292;[];;[];;;;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;FDA Liver Toxicity Knowledge Base Benchmark Dataset (LTKB-BD) drugs of less concern for DILI;CHEMBL1909281;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909307;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";CHEMBL1909294;Non-molecular target assigned;N;1;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909308;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";CHEMBL1909294;Non-molecular target assigned;N;2;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909309;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";CHEMBL1909294;Non-molecular target assigned;N;3;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909310;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";CHEMBL1909294;Non-molecular target assigned;N;4;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909311;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";CHEMBL1909294;Non-molecular target assigned;N;5;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909312;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";CHEMBL1909294;Non-molecular target assigned;N;6;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909313;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";CHEMBL1909294;Non-molecular target assigned;N;7;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909314;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";CHEMBL1909294;Non-molecular target assigned;N;8;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909315;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";CHEMBL1909294;Non-molecular target assigned;N;9;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909316;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";CHEMBL1909294;Non-molecular target assigned;N;10;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909317;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";CHEMBL1909294;Non-molecular target assigned;N;11;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909318;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";CHEMBL1909294;Non-molecular target assigned;N;12;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909319;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";CHEMBL1909294;Non-molecular target assigned;N;13;1;CHEMBL1697861;CHEMBL3559723;
CLD0;;;CHEMBL1909320;[];;[];;;;;Liver;A;ADME;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";CHEMBL1909294;Non-molecular target assigned;N;14;1;CHEMBL1697861;CHEMBL3559723;
CLD0;confirmatory;MDA-N;CHEMBL1963976;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307532;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;87;7;CHEMBL614078;;
CLD0;confirmatory;SN12C;CHEMBL1963981;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;145;7;CHEMBL614054;;
CLD0;confirmatory;NCI-H23;CHEMBL1963985;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;1;7;CHEMBL614997;;
CLD0;confirmatory;ACHN;CHEMBL1963989;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;139;7;CHEMBL614519;;
CLD0;confirmatory;UO-31;CHEMBL1963990;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;143;7;CHEMBL614388;;
CLD0;confirmatory;HOP-92;CHEMBL1963991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;13;7;CHEMBL613889;;
CLD0;confirmatory;HL-60;CHEMBL1963994;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307654;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;125;7;CHEMBL383;;
CLD0;confirmatory;DU-145;CHEMBL1964017;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;43;7;CHEMBL613508;;
CLD0;confirmatory;SF-539;CHEMBL1964018;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;49;7;CHEMBL614860;;
CLD0;confirmatory;SK-MEL-5;CHEMBL1964021;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;37;7;CHEMBL614922;;
CLD0;confirmatory;Malme-3M;CHEMBL1964025;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307507;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;29;7;CHEMBL614021;;
CLD0;confirmatory;K562;CHEMBL1964030;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;121;7;CHEMBL385;;
CLD0;confirmatory;A498;CHEMBL1964034;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;129;7;CHEMBL614516;;
CLD0;confirmatory;OVCAR-3;CHEMBL1964037;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;99;7;CHEMBL614213;;
CLD0;confirmatory;MOLT-4;CHEMBL1964040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307557;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;123;7;CHEMBL614177;;
CLD0;confirmatory;HOP-62;CHEMBL1964043;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;9;7;CHEMBL614643;;
CLD0;confirmatory;NCI/ADR-RES;CHEMBL1964045;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;93;7;CHEMBL613829;;
CLD0;confirmatory;U-251;CHEMBL1964047;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;59;7;CHEMBL615022;;
CLD0;confirmatory;OVCAR-8;CHEMBL1964048;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;109;7;CHEMBL612555;;
CLD0;confirmatory;OVCAR-5;CHEMBL1964049;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;107;7;CHEMBL614214;;
CLD0;confirmatory;SNB-19;CHEMBL1964059;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;53;7;CHEMBL614164;;
CLD0;confirmatory;DMS-273;CHEMBL1964062;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308487;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;61;7;CHEMBL614034;;
CLD0;confirmatory;MDA-MB-231;CHEMBL1964063;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307960;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;95;7;CHEMBL400;;
CLD0;confirmatory;SR;CHEMBL1964065;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307586;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;115;7;CHEMBL614300;;
CLD0;confirmatory;TK-10;CHEMBL1964066;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;141;7;CHEMBL614056;;
CLD0;confirmatory;SW-620;CHEMBL1964072;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;81;7;CHEMBL612262;;
CLD0;confirmatory;M19-MEL;CHEMBL1964074;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307506;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;27;7;CHEMBL614019;;
CLD0;confirmatory;NCI-H522;CHEMBL1964075;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;15;7;CHEMBL614387;;
CLD0;confirmatory;KM12;CHEMBL1964077;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;73;7;CHEMBL614709;;
CLD0;confirmatory;M14;CHEMBL1964085;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;25;7;CHEMBL614317;;
CLD0;confirmatory;XF498;CHEMBL1964086;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308037;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;51;7;CHEMBL613533;;
CLD0;confirmatory;NCI-H322M;CHEMBL1964087;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307710;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;5;7;CHEMBL614803;;
CLD0;confirmatory;RPMI-8226;CHEMBL1964088;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307732;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;113;7;CHEMBL614882;;
CLD0;confirmatory;OVCAR-4;CHEMBL1964091;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;105;7;CHEMBL614051;;
CLD0;confirmatory;LOX IMVI ;CHEMBL1964092;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307535;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;23;7;CHEMBL614096;;
CLD0;confirmatory;P388;CHEMBL1964095;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308401;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;111;7;CHEMBL389;;
CLD0;confirmatory;BT-549;CHEMBL1964099;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;89;7;CHEMBL614072;;
CLD0;confirmatory;SK-MEL-2;CHEMBL1963844;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;35;7;CHEMBL614917;;
CLD0;confirmatory;KM-20L2;CHEMBL1963848;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307782;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;75;7;CHEMBL614791;;
CLD0;confirmatory;A549;CHEMBL1963854;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;19;7;CHEMBL392;;
CLD0;confirmatory;HCC 2998;CHEMBL1963860;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308074;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;77;7;CHEMBL613855;;
CLD0;confirmatory;SNB-75;CHEMBL1963866;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;55;7;CHEMBL614451;;
CLD0;confirmatory;HCT-15;CHEMBL1963868;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;71;7;CHEMBL612263;;
CLD0;confirmatory;HCT-116;CHEMBL1963874;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;79;7;CHEMBL394;;
CLD0;confirmatory;SF-268;CHEMBL1963876;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;45;7;CHEMBL613977;;
CLD0;confirmatory;EKVX ;CHEMBL1963880;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;21;7;CHEMBL614487;;
CLD0;confirmatory;MCF7;CHEMBL1963882;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;83;7;CHEMBL387;;
CLD0;confirmatory;PC-3;CHEMBL1963885;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;41;7;CHEMBL390;;
CLD0;confirmatory;DMS-114;CHEMBL1963887;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307670;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;63;7;CHEMBL614642;;
CLD0;confirmatory;LXFL 529;CHEMBL1963889;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307537;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;17;7;CHEMBL614110;;
CLD0;confirmatory;SK-OV-3;CHEMBL1963895;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;103;7;CHEMBL614925;;
CLD0;confirmatory;T47D;CHEMBL1963900;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;91;7;CHEMBL614361;;
CLD0;confirmatory;NCI-H460;CHEMBL1963901;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;7;7;CHEMBL396;;
CLD0;confirmatory;UACC-62;CHEMBL1963903;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;31;7;CHEMBL614610;;
CLD0;confirmatory;CAKI-1;CHEMBL1963911;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;131;7;CHEMBL614067;;
CLD0;confirmatory;P388/ADR;CHEMBL1963918;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307566;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;117;7;CHEMBL614218;;
CLD0;confirmatory;MDA-MB-435;CHEMBL1963921;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;85;7;CHEMBL614697;;
CLD0;confirmatory;SF-295;CHEMBL1963922;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;47;7;CHEMBL614908;;
CLD0;confirmatory;IGROV-1;CHEMBL1963929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;101;7;CHEMBL613984;;
CLD0;confirmatory;RXF 631;CHEMBL1963935;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307735;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;135;7;CHEMBL614888;;
CLD0;confirmatory;;CHEMBL1963940;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PUBCHEM_BIOASSAY: Biochemical firefly luciferase enzyme assay for NPC. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624030;7;CHEMBL5567;;
CLD0;confirmatory;Hs-578T;CHEMBL1963945;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307672;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;97;7;CHEMBL614645;;
CLD0;confirmatory;786-0;CHEMBL1963953;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;137;7;CHEMBL613102;;
CLD0;confirmatory;SNB-78;CHEMBL1963954;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307969;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;57;7;CHEMBL612543;;
CLD0;confirmatory;UACC-257;CHEMBL1963960;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;33;7;CHEMBL612796;;
CLD0;confirmatory;CCRF-CEM;CHEMBL1963961;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;119;7;CHEMBL382;;
CLD0;confirmatory;DLD-1;CHEMBL1963963;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307580;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;69;7;CHEMBL614285;;
CLD0;confirmatory;NCI-H226;CHEMBL1964004;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307697;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;3;7;CHEMBL614740;;
CLD0;confirmatory;HT-29;CHEMBL1964006;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;65;7;CHEMBL384;;
CLD0;confirmatory;SK-MEL-28;CHEMBL1964007;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;39;7;CHEMBL614919;;
CLD0;confirmatory;RXF 393;CHEMBL1964009;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;133;7;CHEMBL614886;;
CLD0;confirmatory;COLO 205;CHEMBL1964012;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;67;7;CHEMBL614561;;
CLD0;confirmatory;HOP-18;CHEMBL1964014;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307783;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;11;7;CHEMBL614809;;
CLD0;confirmatory;SN12K1;CHEMBL1964015;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307784;Target assigned is non-molecular;1;PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;127;7;CHEMBL1909241;;
CLD0;;HepG2;CHEMBL2078604;[];;[];;;;In vitro;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307718;Homologous single protein target assigned;8;TP_TRANSPORTER: inhibition of bimane-GS efflux in the presence of 6-thioguanine at a concentration of 100uM in MRP4-expressing HepG2 cells;CHEMBL2073968;Homologous protein target assigned;H;3460;18;CHEMBL1743128;;
CLD0;confirmatory;;CHEMBL2114843;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624296;7;CHEMBL1293278;;
CLD0;confirmatory;;CHEMBL2114738;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624170;7;CHEMBL2146302;;
CLD0;confirmatory;;CHEMBL2114775;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;651820;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2114784;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;651635;7;CHEMBL1795085;;
CLD0;confirmatory;;CHEMBL2114916;[];Trypanosoma brucei;[];;;5691.0;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;624173;7;CHEMBL2146316;;
CLD0;confirmatory;;CHEMBL2114924;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ;CHEMBL1201862;Direct protein target assigned;D;624246;7;CHEMBL1293191;;
CLD0;;T47D;CHEMBL3074331;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307606;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) T47D cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539750;1;CHEMBL614361;;
CLD0;;BT-549;CHEMBL3074333;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308490;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) BT549 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539749;1;CHEMBL614072;;
CLD0;;Hs-578T;CHEMBL3074334;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307672;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) Hs 578T cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539748;1;CHEMBL614645;;
CLD0;;MCF7;CHEMBL3074752;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308403;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) MCF7 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539746;1;CHEMBL387;;
CLD0;;DU-145;CHEMBL3074753;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308034;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) DU145 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539745;1;CHEMBL613508;;
CLD0;;RXF 393;CHEMBL3074754;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) RXF393 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539743;1;CHEMBL614886;;
CLD0;;PC-3;CHEMBL3074755;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307570;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) PC3 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539744;1;CHEMBL390;;
CLD0;;UO-31;CHEMBL3074756;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) UO31 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539742;1;CHEMBL614388;;
CLD0;;SN12C;CHEMBL3074757;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307518;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SN12C cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539740;1;CHEMBL614054;;
CLD0;;TK-10;CHEMBL3074758;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308453;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) TK10 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539741;1;CHEMBL614056;;
CLD0;;CAKI-1;CHEMBL3074759;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307522;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) CAKI-1 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539739;1;CHEMBL614067;;
CLD0;;A498;CHEMBL3074760;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308425;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) A498 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539737;1;CHEMBL614516;;
CLD0;;ACHN;CHEMBL3073381;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307633;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) ACHN cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539738;1;CHEMBL614519;;
CLD0;;786-0;CHEMBL3073382;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308018;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) 786-0 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539736;1;CHEMBL613102;;
CLD0;;NCI/ADR-RES;CHEMBL3073383;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308057;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) NCI/ADR-RES cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539734;1;CHEMBL613829;;
CLD0;;SK-OV-3;CHEMBL3073384;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307746;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SKOV3 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539735;1;CHEMBL614925;;
CLD0;;OVCAR-8;CHEMBL3073385;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307975;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) OVCAR8 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539733;1;CHEMBL612555;;
CLD0;;OVCAR-5;CHEMBL3073386;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307565;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) OVCAR5 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539732;1;CHEMBL614214;;
CLD0;;OVCAR-4;CHEMBL3073387;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307517;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) OVCAR4 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539731;1;CHEMBL614051;;
CLD0;;OVCAR-3;CHEMBL3073388;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307564;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) OVCAR3 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539730;1;CHEMBL614213;;
CLD0;;IGROV-1;CHEMBL3073389;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307502;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) IGROV1 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539729;1;CHEMBL613984;;
CLD0;;UACC-62;CHEMBL3073390;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307660;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) UACC62 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539728;1;CHEMBL614610;;
CLD0;;SK-MEL-5;CHEMBL3073391;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307744;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SK-MEL-5 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539726;1;CHEMBL614922;;
CLD0;;UACC-257;CHEMBL3073392;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308008;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) UACC257 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539727;1;CHEMBL612796;;
CLD0;;SK-MEL-28;CHEMBL3073393;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308494;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SK-MEL-28 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539725;1;CHEMBL614919;;
CLD0;;SK-MEL-2;CHEMBL3073394;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307743;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SK-MEL-2 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539724;1;CHEMBL614917;;
CLD0;;MDA-MB-435;CHEMBL3073395;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307686;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) MDA-MB-435 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539723;1;CHEMBL614697;;
CLD0;;M14;CHEMBL3073396;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307591;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) M14 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539722;1;CHEMBL614317;;
CLD0;;Malme-3M;CHEMBL3073397;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307507;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) MALME-3M cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539721;1;CHEMBL614021;;
CLD0;;SNB-75;CHEMBL3073399;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307616;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SNB75 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539718;1;CHEMBL614451;;
CLD0;;U-251;CHEMBL3073400;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) U251 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539719;1;CHEMBL615022;;
CLD0;;SNB-19;CHEMBL3073401;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307552;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SNB19 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539717;1;CHEMBL614164;;
CLD0;;SF-539;CHEMBL3073402;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307721;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SF539 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539716;1;CHEMBL614860;;
CLD0;;SF-295;CHEMBL3073403;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307738;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SF295 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539715;1;CHEMBL614908;;
CLD0;;SF-268;CHEMBL3073404;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307499;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SF268 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539714;1;CHEMBL613977;;
CLD0;;KM12;CHEMBL3073405;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307689;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) KM12 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539712;1;CHEMBL614709;;
CLD0;;SW-620;CHEMBL3073406;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307944;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SW620 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539713;1;CHEMBL612262;;
CLD0;;HT-29;CHEMBL3073407;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307768;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) HT-29 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539711;1;CHEMBL384;;
CLD0;;HCT-15;CHEMBL3073408;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307945;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) HCT15 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539710;1;CHEMBL612263;;
CLD0;;HCT-116;CHEMBL3073848;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308372;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) HCT116 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539709;1;CHEMBL394;;
CLD0;;COLO 205;CHEMBL3072626;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308348;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) COLO205 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539707;1;CHEMBL614561;;
CLD0;;NCI-H460;CHEMBL3072627;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307677;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) NCI-H460 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539705;1;CHEMBL396;;
CLD0;;NCI-H522;CHEMBL3073043;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308392;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) NCI-H522 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539706;1;CHEMBL614387;;
CLD0;;NCI-322M;CHEMBL3073044;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) NCI-322M cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539704;1;CHEMBL3879801;;
CLD0;;HOP-92;CHEMBL3073045;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308091;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) HOP92 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539702;1;CHEMBL613889;;
CLD0;;NCI-H23;CHEMBL3073046;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307750;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) NCI-H23 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539703;1;CHEMBL614997;;
CLD0;;HOP-62;CHEMBL3073047;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307671;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) HOP62 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539701;1;CHEMBL614643;;
CLD0;;A549;CHEMBL3073048;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307651;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) A549/ATCC cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539699;1;CHEMBL392;;
CLD0;;EKVX ;CHEMBL3073049;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307626;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) EKVX cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539700;1;CHEMBL614487;;
CLD0;;SR;CHEMBL3073050;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307586;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) SR cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539698;1;CHEMBL614300;;
CLD0;;RPMI8266;CHEMBL3073052;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) RPMI8266 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539697;1;CHEMBL3879801;;
CLD0;;K562;CHEMBL3073053;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) K562 cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539695;1;CHEMBL385;;
CLD0;;CCRF-CEM;CHEMBL3073054;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307641;Target assigned is non-molecular;1;Anticancer activity against Homo sapiens (human) CCRF-CEM cells by SRB assay;CHEMBL3045605;Non-molecular target assigned;N;539693;1;CHEMBL382;;
CLD0;confirmatory;;CHEMBL2354211;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686971;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354215;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. SA5-Pax8: Cytotoxicity IOSE-T80 Measured in Cell-Based System Using Plate Reader - 7054-07_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;687032;7;CHEMBL2362980;;
CLD0;confirmatory;;CHEMBL2354219;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;686920;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL2354221;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686978;7;CHEMBL1075138;;
CLD0;confirmatory;;CHEMBL2354247;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. PAX8: PAX8-dependent cytotoxicity Measured in Cell-Based System Using Plate Reader - 7054-06_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;687029;7;CHEMBL2362980;;
CLD0;confirmatory;;CHEMBL2354254;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686979;7;CHEMBL1075138;;
CLD0;confirmatory;RMG-I;CHEMBL2354301;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308778;Homologous single protein target assigned;8;PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;687027;7;CHEMBL2362980;;
CLD0;confirmatory;;CHEMBL2354311;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Homologous single protein target assigned;8;PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ;CHEMBL1201862;Homologous protein target assigned;H;686970;7;CHEMBL2007625;;
CLD0;;CHO;CHEMBL3039488;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;1;1;CHEMBL1697668;;
CLD0;;CHO;CHEMBL3039491;[];Cricetulus griseus;[];;;10029.0;In vitro;;A;ADME;BAO_0000219;cell-based format;CHEMBL3308072;Homologous single protein target assigned;8;Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM;CHEMBL3039007;Homologous protein target assigned;H;4;1;CHEMBL1743121;;
CLD0;;CHO-K1;CHEMBL3090301;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Antagonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin assessed as inhibition of agonist-induced effect at 50 uM after 15 mins by luminometric analysis relative to haloperidol;CHEMBL3085742;Direct protein target assigned;D;606532;1;CHEMBL217;;
CLD0;;CHO-K1;CHEMBL3088732;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Agonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin at 100 uM by luminometric analysis relative to quinpirol;CHEMBL3085742;Direct protein target assigned;D;606530;1;CHEMBL217;;
CLD0;;CHO-K1;CHEMBL3088734;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Antagonist activity at human recombinant dopamine D1 receptor expressed in CHOK1 cells assessed as inhibition of agonist-induced cAMP accumulation at 100 uM preincubated for 10 mins prior to agonist addition measured after 30 mins by HTRF assay relative to SCH23390;CHEMBL3085742;Direct protein target assigned;D;606527;1;CHEMBL2056;;
CLD0;;CHO-K1;CHEMBL3088736;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307512;Direct single protein target assigned;9;Agonist activity at human recombinant dopamine D1 receptor expressed in CHOK1 cells assessed as stimulation of cAMP accumulation at 100 uM after 30 mins by HTRF assay relative to SKF81297;CHEMBL3085742;Direct protein target assigned;D;606518;1;CHEMBL2056;;
CLD0;;;CHEMBL3137722;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;1;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137723;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source];CHEMBL3137667;Non-molecular target assigned;N;2;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137724;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;3;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137725;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source];CHEMBL3137667;Non-molecular target assigned;N;4;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137726;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;5;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137727;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;6;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137728;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;7;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137729;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Default value - Target unknown or has yet to be assigned;0;Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;8;1;CHEMBL612545;CHEMBL3559723;
CLD0;;;CHEMBL3137730;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;9;1;CHEMBL612545;;
CLD0;;;CHEMBL3137731;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source];CHEMBL3137667;Non-molecular target assigned;N;10;1;CHEMBL3879801;CHEMBL3559723;
CLD0;;;CHEMBL3137732;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;11;1;CHEMBL612545;;
CLD0;;;CHEMBL3137733;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;12;1;CHEMBL612545;;
CLD0;;;CHEMBL3137734;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;13;1;CHEMBL612545;;
CLD0;;;CHEMBL3137735;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source];CHEMBL3137667;Non-molecular target assigned;N;14;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137736;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Animal toxicity known. [column 'TOXIC' in source];CHEMBL3137667;Non-molecular target assigned;N;15;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137737;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Presence of at least one case with successful reintroduction. [column 'REINT' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;16;1;CHEMBL612545;;
CLD0;;;CHEMBL3137738;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Comments (NB not yet translated). [column 'COMMENTAIRES' in source];CHEMBL3137667;Default value - Target has yet to be curated;U;17;1;CHEMBL612545;;
CLD0;;;CHEMBL3137739;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source];CHEMBL3137667;Non-molecular target assigned;N;18;1;CHEMBL3879801;;
CLD0;;;CHEMBL3137740;[];Homo sapiens;[];;;9606.0;;Liver;T;Toxicity;BAO_0000221;tissue-based format;;Target assigned is non-molecular;1;Proposed mechanism(s) of liver damage. [column 'MEC' in source];CHEMBL3137667;Non-molecular target assigned;N;19;1;CHEMBL3879801;CHEMBL3559723;
CLD0;confirmatory;;CHEMBL3214929;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent TC71 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-04_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720570;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214945;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation.   (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;743344;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3215001;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;743345;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3215017;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720579;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215040;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Luminescence cell-based Retest at Dose assay to determine EWS/Fli1 dependent A673 mammalian cell cytotoxity  Measured in Cell-Based System Using Plate Reader - 7014-03_Inhibitor_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720587;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215169;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720533;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215177;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. PAX8: non-specific cytotoxicity Measured in Cell-Based System Using Plate Reader - 7054-05_Inhibitor_Dose_DryPowder_Activity.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;743021;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215181;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;"PubChem BioAssay. qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen.   (Class of assay: confirmatory) ";CHEMBL1201862;Default value - Target has yet to be curated;U;720542;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3215270;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720580;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214813;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2).   (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;743346;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3214842;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Target assigned is non-molecular;1;PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation.   (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;743347;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3214911;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;PubChem BioAssay. HEK293 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-01_Inhibitor_Dose_CherryPick_Activity_Set3. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;720588;7;CHEMBL3879801;;
CLD0;confirmatory;;CHEMBL3214913;[];;[];;;;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;720532;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3214923;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;PubChem BioAssay. HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_CherryPick_Activity_Set3. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ;CHEMBL1201862;Non-molecular target assigned;N;720589;7;CHEMBL3879801;;
CLD0;;;CHEMBL3239455;[];Escherichia coli;[];;;562.0;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Inhibition of GST-tagged Escherichia coli HPPK expressed in Escherichia coli using 6-hydroxymethyl-7,8-dihydropterin hydrochloride as substrate at 250 uM after 20 mins by luminescence assay;CHEMBL3232813;Homologous protein target assigned;H;644093;1;CHEMBL3217379;;
CLD0;;;CHEMBL3239457;[];Escherichia coli;[];;;562.0;;;B;Binding;BAO_0000019;assay format;;Homologous single protein target assigned;8;Binding affinity to GST-tagged Escherichia coli HPPK expressed in Escherichia coli by SPR assay based alternative equilibrium affinity method in presence of AMP-CPP;CHEMBL3232813;Homologous protein target assigned;H;644111;1;CHEMBL3217379;;
CLD0;;T3M4;CHEMBL3535794;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human T3M4 cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650028;1;CHEMBL3879801;;
CLD0;;COLO357;CHEMBL3535795;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307702;Target assigned is non-molecular;1;Cytotoxicity against human Colo-357 cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650029;1;CHEMBL3879801;;
CLD0;;PaTu 8988t;CHEMBL3535796;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL4295420;Target assigned is non-molecular;1;Cytotoxicity against human Patu-T cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650030;1;CHEMBL3879801;;
CLD0;;Patu-S;CHEMBL3536117;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human Patu-S cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650051;1;CHEMBL3879801;;
CLD0;;ASPC1;CHEMBL3536118;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307994;Target assigned is non-molecular;1;Cytotoxicity against human Aspc-1 cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650052;1;CHEMBL3879801;;
CLD0;;PANC-1;CHEMBL3536119;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307545;Target assigned is non-molecular;1;Cytotoxicity against human PANC1 cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650053;1;CHEMBL3879801;;
CLD0;;Patu-02;CHEMBL3536120;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;;Target assigned is non-molecular;1;Cytotoxicity against human Patu-02 cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650054;1;CHEMBL3879801;;
CLD0;;DAN-G;CHEMBL3536121;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307281;Target assigned is non-molecular;1;Cytotoxicity against human DAN-G cells by crystal violet staining;CHEMBL3525937;Non-molecular target assigned;N;650055;1;CHEMBL614033;;
CLD0;confirmatory;;CHEMBL3561973;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117303;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561990;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117310;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3561991;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117349;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3561996;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117338;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562021;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. RKO viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117322;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562024;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117324;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562026;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117347;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562027;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117332;7;CHEMBL612545;;
CLD0;confirmatory;SNU-C1;CHEMBL3562038;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308249;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117323;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562043;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117337;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562064;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117314;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562069;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117334;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562085;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117318;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562088;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117315;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562112;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117311;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562115;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117348;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562119;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117298;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562120;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117351;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562123;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117330;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562124;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117352;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562130;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117339;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562133;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117302;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562135;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117301;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562136;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117304;7;CHEMBL612545;;
CLD0;confirmatory;HeLa;CHEMBL3562139;[];;[];;;;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308376;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117350;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562146;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117305;7;CHEMBL612545;;
CLD0;confirmatory;;CHEMBL3562152;[];;[];;;;;;F;Functional;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ;CHEMBL1201862;Default value - Target has yet to be curated;U;1117312;7;CHEMBL612545;;
871272;;RXF 393;CHEMBL3866457;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307734;Target assigned is non-molecular;1;Cytotoxicity against human RFX393 cells measured after 48 hrs by SRB assay;CHEMBL3865806;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871256;;UO-31;CHEMBL3866461;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307612;Target assigned is non-molecular;1;Cytotoxicity against human UO31 cells measured after 48 hrs by SRB assay;CHEMBL3865806;Non-molecular target assigned;N;;1;CHEMBL3879801;;
871273;;U-251;CHEMBL3866468;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307756;Target assigned is non-molecular;1;Cytotoxicity against human U251 cells measured after 48 hrs by SRB assay;CHEMBL3865806;Non-molecular target assigned;N;;1;CHEMBL3879801;;
1;;;CHEMBL3885882;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Daily Repeat', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Daily Repeat', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 50 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
2;;;CHEMBL3885883;[];Schistosoma mansoni;[{'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': '6-8', 'standard_type': 'AGE', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': '6-8', 'type': 'AGE', 'units': 'weeks', 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Male', 'standard_type': 'GENDER', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Male', 'type': 'GENDER', 'units': None, 'value': None}, {'active': 1, 'comments': None, 'relation': None, 'standard_relation': None, 'standard_text_value': 'Single', 'standard_type': 'REGIMEN', 'standard_type_fixed': 0, 'standard_units': None, 'standard_value': None, 'text_value': 'Single', 'type': 'REGIMEN', 'units': None, 'value': None}];Puerto Rican;;6183.0;In vivo;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;In vitro activity on S. mansoni schistosomula at 10 uM;CHEMBL3885881;Non-molecular target assigned;N;;15;CHEMBL612893;;
911630;;;CHEMBL4029349;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
911633;;;CHEMBL4029350;[];Homo sapiens;[];;;9606.0;;;T;Toxicity;BAO_0000019;assay format;;Target assigned is non-molecular;1;Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status;CHEMBL4028802;Non-molecular target assigned;N;;1;CHEMBL372;;
1_ELL;;Caco-2;CHEMBL4303805;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
2_ELL;;Caco-2;CHEMBL4303806;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL3307519;Target assigned is non-molecular;1;Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL4303835;;
3_ELL;;Caco-2;CHEMBL4303807;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL3307519;Target assigned is non-molecular;1;Toxicity against Caco-2 cells determined at 48 hours by intracellular ATP concentration using the CellTiter-Glo Luminescent Cell Viability Assay;CHEMBL4303101;Non-molecular target assigned;N;;52;CHEMBL614058;;
4_ELL;;Caco-2;CHEMBL4303808;[];Homo sapiens;[];;;9606.0;In vitro;;T;Toxicity;BAO_0000219;cell-based format;;Default value - Target unknown or has yet to be assigned;0;Cytotoxicity index (CI): selectivity for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells versus toxicity against Caco-2 cells (CC50/IC50);CHEMBL4303101;Default value - Target has yet to be curated;U;;52;CHEMBL612558;;
1_HEI;;HRCE;CHEMBL4303810;[];Homo sapiens;[];;;9606.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4303839;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits);CHEMBL4303122;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1_TOU;;Vero C1008;CHEMBL4303819;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs;CHEMBL4303097;Non-molecular target assigned;N;;52;CHEMBL4303835;;
1160271;;THP-1;CHEMBL4420581;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 (+/+) cells expressing wild type SAMHD1 to cytotoxic IC50 for human THP1 cells with CRISP/CAS9 SAMHD1 knockout;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160272;;THP-1;CHEMBL4420582;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Ratio of cytotoxic IC50 for human THP1 cells with constitutively expressing high SAMHD1 expression to cytotoxic IC50 for parental human THP1 cells expressing low SAMHD1 expression;CHEMBL4420068;Non-molecular target assigned;N;;38;CHEMBL614245;;
1160311;;;CHEMBL4420590;[];Homo sapiens;[];;;9606.0;;;B;Binding;BAO_0000019;assay format;;Direct single protein target assigned;9;Substrate activity at SAMHD1 (unknown origin) expressed in bacterial system expressed in bacteria assessed as triphospho-hydolase activity by measuring cytarabine tri-phosphate formation;CHEMBL4420068;Direct protein target assigned;D;;38;CHEMBL4523507;;
845901;;;CHEMBL4478999;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Drug activation in human Hep3B cells assessed as human CYP2C9-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone;CHEMBL4477225;Direct protein target assigned;D;;1;CHEMBL3397;;
845714;;;CHEMBL4479000;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Drug activation in human Hep3B cells assessed as human CYP3A4-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone;CHEMBL4477225;Direct protein target assigned;D;;1;CHEMBL340;;
845813;;;CHEMBL4479083;[];Homo sapiens;[];;;9606.0;;;A;ADME;BAO_0000219;cell-based format;;Direct single protein target assigned;9;Drug activation in human Hep3B cells assessed as human CYP2D6-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone;CHEMBL4477225;Direct protein target assigned;D;;1;CHEMBL289;;
1_KUZ;;;CHEMBL4495582;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;In vitro;;F;Functional;BAO_0000019;assay format;;Direct single protein target assigned;9;SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate;CHEMBL4495564;Direct protein target assigned;D;;52;CHEMBL4523582;;
1_LEY;;Vero C1008;CHEMBL4513082;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4495565;Non-molecular target assigned;N;;52;CHEMBL4303835;;
CARE_1_ELL;;Vero C1008;CHEMBL4651403;[];Chlorocebus sabaeus;[];;;60711.0;In vitro;;F;Functional;BAO_0000218;organism-based format;CHEMBL4295411;Target assigned is non-molecular;1;Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging;CHEMBL4651402;Non-molecular target assigned;N;;57;CHEMBL4303835;;
1257836;;;CHEMBL4723481;[];Severe acute respiratory syndrome-related coronavirus;[];;;694009.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of SARS-CoV C-terminal 6His-tagged papain-like protease expressed in Escherichia coli BL21(DE3) using ubiquitin-AMC as substrate preincubated for 10 mins followed by substrate addition by luminescence spectrometric method;CHEMBL4715856;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1330471;;;CHEMBL4826250;[];Helicobacter pylori;[];;;210.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Substrate activity at Helicobacter pylori XGHPRT assessed as Kcat using purine base and PRib-PP as substrate measured for 60 sec by spectrophotometric method;CHEMBL4825670;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1330472;;;CHEMBL4826251;[];Helicobacter pylori;[];;;210.0;;;A;ADME;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Substrate activity at hexa-his tagged Helicobacter pylori XGHPRT assessed as apparent Km using purine base and PRib-PP as substrate measured for 60 sec by spectrophotometric method;CHEMBL4825670;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1330496;;;CHEMBL4826254;[];Helicobacter pylori;[];;;210.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antibacterial activity against Helicobacter pylori assessed growth inhibition at 50 uM incubated for 3 days;CHEMBL4825670;Non-molecular target assigned;N;;1;CHEMBL612600;;
1408218;;;CHEMBL5139900;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of TAP-tagged SARS-CoV-2 papain-like protease nsp123;CHEMBL5137028;Direct protein target assigned;D;;1;CHEMBL4523582;;
1408219;;;CHEMBL5139901;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of TAP-tagged SARS-CoV-2 papain-like protease nsp23;CHEMBL5137028;Direct protein target assigned;D;;1;CHEMBL4523582;;
1408222;;;CHEMBL5139902;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of SARS-CoV-2 papain-like protease-mediated de-ISGylation;CHEMBL5137028;Direct protein target assigned;D;;1;CHEMBL4523582;;
1408223;;;CHEMBL5139903;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;B;Binding;BAO_0000357;single protein format;;Direct single protein target assigned;9;Inhibition of SARS-CoV-2 papain-like protease;CHEMBL5137028;Direct protein target assigned;D;;1;CHEMBL4523582;;
1408224;;Vero E6;CHEMBL5139904;[];Severe acute respiratory syndrome coronavirus 2;[];;;2697049.0;;;F;Functional;BAO_0000218;organism-based format;;Target assigned is non-molecular;1;Antiviral activity against SARS-CoV-2 infected in African green monkey Vero E6 cells assessed as viral growth inhibition;CHEMBL5137028;Non-molecular target assigned;N;;1;CHEMBL4303835;;
1408225;;Vero C1008;CHEMBL5139905;[];Chlorocebus sabaeus;[];;;60711.0;;;T;Toxicity;BAO_0000219;cell-based format;CHEMBL4295411;Target assigned is non-molecular;1;Cytotoxicity against African green monkey Vero E6 cells assessed as cell viability;CHEMBL5137028;Non-molecular target assigned;N;;1;CHEMBL4303840;;
1444127;;;CHEMBL5150433;[];Severe acute respiratory syndrome coronavirus;[];;;694009.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of SARS-CoV Papain-like protease;CHEMBL5149968;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1444134;;;CHEMBL5150434;[];Middle East respiratory syndrome-related coronavirus;[];;;1335626.0;;;B;Binding;BAO_0000019;assay format;;Default value - Target unknown or has yet to be assigned;0;Inhibition of MERS coronavirus full-length USP2 catalytic domain (258 to 605 residues) expressed in Escherichia coli Rosetta (DE3) using ubiquitin-7-amino-4-trifluoromethylcoumarin as substrate by luminescence based spectrometer analysis;CHEMBL5149968;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1439303;;HEK-293T;CHEMBL5218117;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3706569;Target assigned is non-molecular;1;Antiproliferative activity against HEK293T cells with high HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay;CHEMBL5214997;Non-molecular target assigned;N;;1;CHEMBL3706568;;
1439304;;K562;CHEMBL5218118;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay;CHEMBL5214997;Non-molecular target assigned;N;;1;CHEMBL385;;
1439305;;THP-1;CHEMBL5218119;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3307574;Target assigned is non-molecular;1;Antiproliferative activity against human THP-1 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay;CHEMBL5214997;Non-molecular target assigned;N;;1;CHEMBL614245;;
1439306;;SK-BR-3;CHEMBL5218120;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308062;Target assigned is non-molecular;1;Antiproliferative activity against human SK-BR-3 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay;CHEMBL5214997;Non-molecular target assigned;N;;1;CHEMBL613834;;
1439307;;K562;CHEMBL5218121;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Target assigned is non-molecular;1;Antiproliferative activity against human K562 cells with low HGPRT expression assessed as cell survival at 1000 uM and incubated for 48 hrs by CellTiter-Glo2 assay;CHEMBL5214997;Non-molecular target assigned;N;;1;CHEMBL385;;
1439308;;SK-BR-3;CHEMBL5218122;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308062;Target assigned is non-molecular;1;Drug resistance of human SK-BR-3 cells assessed as percentage of resistant cells at 1 mM;CHEMBL5214997;Non-molecular target assigned;N;;1;CHEMBL613834;;
1439309;;K562;CHEMBL5218123;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308378;Default value - Target unknown or has yet to be assigned;0;Downregulation of HGPRT mRNA expression in human K562 cells at 1 mM measured after 48 hrs by qPCR analysis;CHEMBL5214997;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
1439310;;SK-BR-3;CHEMBL5218124;[];Homo sapiens;[];;;9606.0;;;F;Functional;BAO_0000219;cell-based format;CHEMBL3308062;Default value - Target unknown or has yet to be assigned;0;Downregulation of HGPRT mRNA expression in human SK-BR-3 cells at 1 mM measured after 48 hrs by qPCR analysis;CHEMBL5214997;Default value - Target has yet to be curated;U;;1;CHEMBL612545;;
